TREATMENT OF EXPERIMENTAL PNEUMOCYSTIS-CARINII INFECTION BY COMBINATION OF CLARITHROMYCIN AND SULFAMETHOXAZOLE

被引:10
作者
ALDER, J
MITTEN, M
SHIPKOWITZ, N
HERNANDEZ, L
HUI, YH
MARSH, K
CLEMENT, J
机构
[1] Anti-Infective Research Division, Abbott Laboratories, Illinois
关键词
D O I
10.1093/jac/33.2.253
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The efficacy of clarithomycin and sulphamethoxazole for treatment of experimental Pneumocystis carinii infection was investigated. Rats were immunosuppressed with dexamethasone and inoculated intratracheally with 5 × 106 P. carinii cysts. After 2 weeks, the lung tissues were assayed for P. carinii cyst burden. The combination of clarithromycin and sulphamethoxazole caused a significantly greater reduction in cyst burden than either drug alone. Up to 50% of the rats treated with the combination of clarithromycin and sulphamethoxazole were negative for P. carinii cysts. Equivalent doses of the individual drugs given alone did not produce cures. The combination of clarithromycin and sulphamethoxazole was more than twice as effective as either drug alone. Clarithromycin combined with sulphamethoxazole in treatment of P. carinii infection could be especially useful since clarithromycin monotherapy provides safe and effective treatment against many other pathogens, including several that are associated with AIDS. © 1994 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:253 / 263
页数:11
相关论文
共 26 条
[1]   NEW RAT MODEL OF PNEUMOCYSTIS-CARINII INFECTION [J].
BARTLETT, MS ;
FISHMAN, JA ;
QUEENER, SF ;
DURKIN, MM ;
JAY, MA ;
SMITH, JW .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (06) :1100-1102
[2]   MODELS FOR EVALUATING COMPOUNDS FOR ACTIVITY AGAINST PNEUMOCYSTIS-CARINII [J].
BARTLETT, MS .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (03) :199-201
[3]   CLINDAMYCIN AND PRIMAQUINE AS PRIMARY-TREATMENT FOR MILD AND MODERATELY SEVERE PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS [J].
BLACK, JR ;
FEINBERG, J ;
MURPHY, RL ;
FASS, RJ ;
CAREY, J ;
SATTLER, FR .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (03) :204-207
[4]   LOW-DOSE TRIMETHOPRIM-SULFAMETHOXAZOLE ALONE AND IN ASSOCIATION WITH ZIDOVUDINE FOR PREVENTION AND TREATMENT OF MURINE PNEUMOCYSTIS-CARINII PNEUMONIA [J].
BRUNPASCAUD, M ;
GIRARD, PM ;
POCIDALO, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) :2328-2330
[5]   RECENT ADVANCES IN THE DIAGNOSIS, TREATMENT, AND PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA [J].
DAVEY, RT ;
MASUR, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (04) :499-504
[6]  
DORLEMANN A, 1989, 5TH INT C AIDS
[7]   BIOASSAY FOR A-56268 (TE-031) AND IDENTIFICATION OF ITS MAJOR METABOLITE, 14-HYDROXY-6-O-METHYL ERYTHROMYCIN [J].
FERNANDES, PB ;
RAMER, N ;
RODE, RA ;
FREIBERG, L .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (01) :73-76
[8]   THE DIFFUSION OF CLARITHROMYCIN AND ROXITHROMYCIN INTO NASAL-MUCOSA, TONSIL AND LUNG IN HUMANS [J].
FRASCHINI, F ;
SCAGLIONE, F ;
PINTUCCI, G ;
MACCARINELLI, G ;
DUGNANI, S ;
DEMARTINI, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 :61-65
[9]   PNEUMOCYSTIS-CARINII PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].
GLATT, AE ;
CHIRGWIN, K .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (02) :271-279
[10]   CLARITHROMYCIN, A UNIQUE MACROLIDE - A PHARMACOKINETIC, MICROBIOLOGICAL, AND CLINICAL OVERVIEW [J].
HARDY, DJ ;
GUAY, DRP ;
JONES, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (01) :39-53